An interesting job posting from Amgen which listed the required expertise on certain advanced techniques. Has Dr. Liau mentioned these techniques extensively in her publications? Absolutely! Here are some publications as illustration.
Expert knowledge in the analysis of protein-based therapies with advanced techniques such as capillary electrophoresis, liquid chromatography, and mass spectrometry
"The resulting PCR products were sequenced using bidirectional dye-terminator fluorescent sequencing with universal M13 primers. Sequencing fragments were detected via capillary electrophoresis using ABI Prism 3730 DNA Analyzer (Applied Biosystems, http://appliedbiosystems.com)"
"Metabolites extracted from exponentially growing cells were profiled by liquid chromatography - electrospray ionization - mass spectrometry (LC-MS). In initial survey analyses, full-scan LC-MS in negative ion mode (exact mass) was used to examine differences in metabolite species with an m/z between 110 and 1000."
mass spectrometry
Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1
"Mass spectrometry was performed on a 6460 triple quadrupole LC/MS system (Agilent). Ionization was achieved by using positive ion electrospray ionization and data acquisition was made in multiple reaction monitoring mode."
Here the company Agilent was mentioned. The first thought coming to my mind without google searching was that Merck must have collaboration or partnership with this company. Indeed, Merck did have collaboration with Agilent.
Merck Announces Collaboration with Agilent Technologies to Fill Industry Gap in Process Analytical Technologies for Downstream Processing https://labbulletin.com/articles/merck
Market Data 
Markets 
AI
